Quest Partners LLC Acquires 922 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Quest Partners LLC grew its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 878.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,027 shares of the medical instruments supplier’s stock after acquiring an additional 922 shares during the period. Quest Partners LLC’s holdings in Mettler-Toledo International were worth $1,540,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Thrivent Financial for Lutherans grew its stake in Mettler-Toledo International by 1,940.6% in the third quarter. Thrivent Financial for Lutherans now owns 18,406 shares of the medical instruments supplier’s stock valued at $27,604,000 after purchasing an additional 17,504 shares in the last quarter. Mizuho Securities USA LLC grew its stake in shares of Mettler-Toledo International by 807.3% in the third quarter. Mizuho Securities USA LLC now owns 14,970 shares of the medical instruments supplier’s stock valued at $22,451,000 after buying an additional 13,320 shares in the last quarter. Empirical Finance LLC increased its holdings in Mettler-Toledo International by 2.1% during the third quarter. Empirical Finance LLC now owns 764 shares of the medical instruments supplier’s stock worth $1,146,000 after buying an additional 16 shares during the last quarter. CIBC Asset Management Inc raised its position in Mettler-Toledo International by 7.8% during the third quarter. CIBC Asset Management Inc now owns 3,107 shares of the medical instruments supplier’s stock worth $4,660,000 after acquiring an additional 224 shares in the last quarter. Finally, Metis Global Partners LLC lifted its stake in Mettler-Toledo International by 7.7% in the third quarter. Metis Global Partners LLC now owns 1,833 shares of the medical instruments supplier’s stock valued at $2,749,000 after acquiring an additional 131 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

MTD opened at $1,160.67 on Wednesday. The business has a fifty day simple moving average of $1,373.15 and a 200 day simple moving average of $1,401.19. Mettler-Toledo International Inc. has a 1 year low of $1,041.49 and a 1 year high of $1,546.93. The company has a market capitalization of $24.49 billion, a PE ratio of 31.29, a price-to-earnings-growth ratio of 3.89 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Equities analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on MTD shares. Robert W. Baird dropped their target price on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Finally, Evercore ISI raised their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of “Hold” and an average target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.